相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。[F-18]- Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer
Daniel Vallboehmer et al.
ANNALS OF SURGERY (2009)
Post-treatment Endoscopic Biopsy Is a Poor-Predictor of Pathologic Response in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer
Inderpal S. Sarkaria et al.
ANNALS OF SURGERY (2009)
Influence of the Baseline 18F-Fluoro-2-deoxy-D-glucose Positron Emission Tomography Results on Survival and Pathologic Response in Patients With Gastroesophageal Cancer Undergoing Chemoradiation
Heta Javeri et al.
CANCER (2009)
The Higher the Decrease in the Standardized Uptake Value of Positron Emission Tomography After Chemoradiation, the Better the Survival of Patients With Gastroesophageal Adenocarcinoma
Heta Javeri et al.
CANCER (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Predictive Value of Initial PET-SUVmax in Patients with Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma
Nabil P. Rizk et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Limited Predictive Value of FDG-PET for Response Assessment in the Preoperative Treatment of Esophageal Cancer: Results of a Prospective Multi-Center Trial (SAKK 75/02)
Bernd Klaeser et al.
ONKOLOGIE (2009)
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
Karin Ribi et al.
SUPPORTIVE CARE IN CANCER (2009)
Staging investigations for oesophageal cancer: a meta-analysis
E. P. M. van Vliet et al.
BRITISH JOURNAL OF CANCER (2008)
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group:: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
Florian Lordick et al.
EUROPEAN JOURNAL OF CANCER (2008)
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Recommendations on the use of F-18-FDG PET in oncology
James W. Fletcher et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG:: A comparative analysis
Ken Herrmann et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction:: The MUNICON phase II trial
Florian Lordick et al.
LANCET ONCOLOGY (2007)
Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy
Min Kyoung Kim et al.
EUROPEAN JOURNAL OF CANCER (2007)
18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response
C. M. Gillham et al.
BRITISH JOURNAL OF CANCER (2006)
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction
Katja Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer
EA Levine et al.
ANNALS OF SURGERY (2006)
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection
N Rizk et al.
ANNALS OF THORACIC SURGERY (2006)
Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer
HL van Westreenen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
O Vrieze et al.
RADIOTHERAPY AND ONCOLOGY (2004)
2-fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
SG Swisher et al.
CANCER (2004)
Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction
JV Räsänen et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings
A Stahl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy:: Results of a prospective trial
RJ Downey et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
P Flamen et al.
ANNALS OF ONCOLOGY (2002)
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging
WA Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
P Flamen et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
